123 related articles for article (PubMed ID: 1149363)
1. Pharmacokinetics and metabolism of lidocaine in patients with renal failure.
Collinsworth KA; Strong JM; Atkinson AJ; Winkle RA; Perlroth F; Harrison DC
Clin Pharmacol Ther; 1975 Jul; 18(1):59-64. PubMed ID: 1149363
[TBL] [Abstract][Full Text] [Related]
2. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
De Martin S; Orlando R; Bertoli M; Pegoraro P; Palatini P
Clin Pharmacol Ther; 2006 Dec; 80(6):597-606. PubMed ID: 17178261
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological activity, metabolism, and pharmacokinetics of glycinexylidide.
Strong JM; Mayfield DE; Atkinson AJ; Burris BC; Raymon F; Webster LT
Clin Pharmacol Ther; 1975 Feb; 17(2):184-94. PubMed ID: 1122677
[TBL] [Abstract][Full Text] [Related]
4. Plasma levels, protein binding, and elimination data of lidocaine and active metabolites in cardiac patients of various ages.
Drayer DE; Lorenzo B; Werns S; Reidenberg MM
Clin Pharmacol Ther; 1983 Jul; 34(1):14-22. PubMed ID: 6861434
[TBL] [Abstract][Full Text] [Related]
5. Chromatographic determination of free lidocaine and its active metabolites in plasma from patients under epidural anesthesia.
Kakiuchi Y; Fukuda T; Miyabe M; Homma M; Toyooka H; Kohda Y
Int J Clin Pharmacol Ther; 2002 Nov; 40(11):493-8. PubMed ID: 12698986
[TBL] [Abstract][Full Text] [Related]
6. Serum concentrations of lidocaine and its metabolites after prolonged infusion in healthy horses.
Dickey EJ; McKenzie HC; Brown KA; de Solis CN
Equine Vet J; 2008 Jun; 40(4):348-52. PubMed ID: 18267881
[TBL] [Abstract][Full Text] [Related]
7. Effect of acute and chronic moderate hypoxia on the kinetics of lidocaine and its metabolites and on regional blood flow.
du Souich P; Saunier C; Hartemann D; Allam M
Pulm Pharmacol; 1992; 5(1):9-16. PubMed ID: 1591467
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic serum lidocaine and metabolite concentrations in patients undergoing electrophysiologic study after discontinuation of intravenous lidocaine infusion.
Estes NA; Manolis AS; Greenblatt DJ; Garan H; Ruskin JN
Am Heart J; 1989 May; 117(5):1060-4. PubMed ID: 2711965
[TBL] [Abstract][Full Text] [Related]
9. Plasma concentrations of lidocaine and its principal metabolites during intermittent epidural anesthesia.
Inoue R; Suganuma T; Echizen H; Ishizaki T; Kushida K; Tomono Y
Anesthesiology; 1985 Sep; 63(3):304-10. PubMed ID: 4025891
[TBL] [Abstract][Full Text] [Related]
10. Lidocaine plasma concentrations following administration of intraoral lidocaine solution.
Greenblatt DJ; Benjamin DM; Willis CR; Harmatz JS; Zinny MA
Arch Otolaryngol; 1985 May; 111(5):298-300. PubMed ID: 3985850
[TBL] [Abstract][Full Text] [Related]
11. Cytochrome P450 1A2 is a major determinant of lidocaine metabolism in vivo: effects of liver function.
Orlando R; Piccoli P; De Martin S; Padrini R; Floreani M; Palatini P
Clin Pharmacol Ther; 2004 Jan; 75(1):80-8. PubMed ID: 14749694
[TBL] [Abstract][Full Text] [Related]
12. Effect of duration of lidocaine infusion and route of cimetidine administration on lidocaine pharmacokinetics.
Powell JR; Foster J; Patterson JH; Cross R; Wargin W
Clin Pharm; 1986 Dec; 5(12):993-8. PubMed ID: 3802729
[TBL] [Abstract][Full Text] [Related]
13. Influence of hydralazine on the pharmacokinetics of orally administered d-propranolol and lidocaine in conscious dogs.
Heinzow BG; Somogyi A; McLean AJ
Arch Int Pharmacodyn Ther; 1987 Mar; 286(1):5-14. PubMed ID: 3592861
[TBL] [Abstract][Full Text] [Related]
14. Plasma lidocaine, monoethylglycinexylidide, and glycinexylidide concentrations after epidural administration in geriatric patients.
Fukuda T; Kakiuchi Y; Miyabe M; Okubo N; Yaguchi Y; Kohda Y; Toyooka H
Reg Anesth Pain Med; 2000; 25(3):268-73. PubMed ID: 10834781
[TBL] [Abstract][Full Text] [Related]
15. Lidocaine elimination and monoethylglycinexylidide formation in patients with chronic hepatitis or cirrhosis.
Testa R; Campo N; Caglieris S; Risso D; Alvarez S; Arzani L; Giannini E; Lantieri PB; Celle G
Hepatogastroenterology; 1998; 45(19):154-9. PubMed ID: 9496506
[TBL] [Abstract][Full Text] [Related]
16. Effect of plasma alpha1-acid glycoprotein concentration on the accumulation of lidocaine metabolites during continuous epidural anesthesia in infants and children.
Kakiuchi Y; Kohda Y; Miyabe M; Momose Y
Int J Clin Pharmacol Ther; 1999 Oct; 37(10):493-8. PubMed ID: 10543316
[TBL] [Abstract][Full Text] [Related]
17. Lidocaine and its active metabolites.
Narang PK; Crouthamel WG; Carliner NH; Fisher ML
Clin Pharmacol Ther; 1978 Dec; 24(6):654-62. PubMed ID: 710024
[TBL] [Abstract][Full Text] [Related]
18. Plasma concentrations of lidocaine and its principal metabolites during continuous epidural infusion of lidocaine with or without epinephrine.
Kihara S; Miyabe M; Kakiuchi Y; Takahashi S; Fukuda T; Kohda Y; Toyooka H
Reg Anesth Pain Med; 1999; 24(6):529-33. PubMed ID: 10588557
[TBL] [Abstract][Full Text] [Related]
19. Determination of lidocaine and its two N-desethylated metabolites in dog and horse plasma by high-performance liquid chromatography combined with electrospray ionization tandem mass spectrometry.
Maes A; Weiland L; Sandersen C; Gasthuys F; De Backer P; Croubels S
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 852(1-2):180-7. PubMed ID: 17296334
[TBL] [Abstract][Full Text] [Related]
20. Maternal, fetal, and neonatal metabolism of lidocaine.
Kuhnert BR; Knapp DR; Kuhnert PM; Prochaska AL
Clin Pharmacol Ther; 1979 Aug; 26(2):213-20. PubMed ID: 455889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
